Zymeworks Snapshot
Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Our fully integrated R&D engine from target selection through to pivotal studies is powered by our team of world-class researchers with the experience to discover, develop and commercialize our novel agents globally with partners and collaborators.
We thrive on scientific challenges and strive to deliver transformational therapies for patients with difficult-to-treat cancers and other serious diseases. Our growing pipeline of novel multifunctional therapeutics is supported by our best-in-class antibody-drug conjugates and multispecific antibody therapeutics technology platforms.
By bringing people together in purpose, we can solve the world’s most challenging medical problems. Using our innovative approach to multifunctional therapeutics, our mission is to improve the lives of patients with difficult-to-treat cancers and other serious diseases.
For additional information please visit www.zymeworks.com.
We thrive on scientific challenges and strive to deliver transformational therapies for patients with difficult-to-treat cancers and other serious diseases. Our growing pipeline of novel multifunctional therapeutics is supported by our best-in-class antibody-drug conjugates and multispecific antibody therapeutics technology platforms.
By bringing people together in purpose, we can solve the world’s most challenging medical problems. Using our innovative approach to multifunctional therapeutics, our mission is to improve the lives of patients with difficult-to-treat cancers and other serious diseases.
For additional information please visit www.zymeworks.com.
